SightfileU.S. market data from official filings

Companies › JSPR

Jasper Therapeutics Inc (JSPR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001788028 · EDGAR filings · Updated 2026-07-23

Jasper Therapeutics Inc (JSPR) has reported institutional ownership of 56.5%, with 58 institutional managers holding positions valued at $13.9M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
56.5%
Institutional managers
58
Reported 13F value
$13.9M
Insider activity
4 trans.
$347.5K net buying
Data flags
3 active
from SEC filings

Filings this week (4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Jasper Therapeutics Inc has 58 institutional holders and institutional ownership of 56.5%.

Insider activity

Insiders reported 4 transactions (4 buys, 0 sells) across 4 reporting insiders, with a net reported value of $347.5K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-09 (recurring since 2022-11-04) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2020-11-10) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-05-18 (recurring since 2021-05-18) — source filing. The authoritative details are those stated in the filing itself.

Related companies

PARK DENTAL PARTNERS INC (PARK) · MOLECULAR PARTNERS AG (MOLN) · QT IMAGING HLDGS INC (QTI) · PASSAGE BIO INC COM NEW (PASG) · EDESA BIOTECH INC COM NEW (EDSA) · POLYPID LTD (PYPD)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.